Products billed under this code include Brixadi (weekly dosing).
Payment limit per Less than or equal to 7 days of therapy, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Brixadi (weekly dosing) | Braeburn Inc. | 58284-0208-01 | 1 | $433.167 |
| Brixadi (weekly dosing) | Braeburn Inc. | 58284-0216-01 | 1 | $433.167 |
| Brixadi (weekly dosing) | Braeburn Inc. | 58284-0224-01 | 1 | $433.167 |
| Brixadi (weekly dosing) | Braeburn Inc. | 58284-0232-01 | 1 | $433.167 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $433.167 | +$2.591 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted September 17, 2026 |
| 3Q26 | $430.576 | +$13.366 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted September 15, 2026 |
| 2Q26 | $417.21 | −$2.843 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted September 15, 2026 |
| 1Q26 | $420.053 | −$0.583 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted September 15, 2026 |
| 4Q25 | $420.636 | −$2.191 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted September 8, 2026 |
| 3Q25 | $422.827 | −$2.577 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted March 10, 2026 |
| 2Q25 | $425.404 | −$3.252 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted March 10, 2026 |
| 1Q25 | $428.656 | −$0.50 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted December 19, 2025 |
| 4Q24 | $429.156 | +$2.185 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted June 11, 2025 |
| 3Q24 | $426.971 | +$22.885 | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted June 11, 2025 |
| 2Q24 | $404.086 | – | Less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
